Abstract
Cardio-renal disease as a disease entity carries with it high morbidity and mortality. This entity is only now being defined and studied, and much of the treatment of these patients is guided by what is known of patient populations with heart failure or kidney failure. There are few disease specific treatments available for CRS and much of the care is focused on symptom management, and is characterized by very high morbidity and mortality burden. Palliative care as a specialty was recognized by the American Board of Medical Specialties in 2006. Given the high symptom burden and complexity of outcomes with the overlap of heart and kidney disease, palliative care is integral to the multi-disciplinary effort required in achieving optimal outcomes in these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bock JS, Gottlieb SS. Cardiorenal syndrome, new perspectives. Circulation. 2010;121:2592–600. doi:10.1161/CIRCULATIONAHA.109.886473.
Shlipak M, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation. 2004;110:1514–7.
Liu PP. Cardiorenal syndrome in heart failure: a cardiologist’s perspective. Can J Cardiol. 2008;24(Suppl B):25B–9B.
Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008;36(1 Suppl):S75.
Bekelman DB, Rumsfeld JS, Havanek EP, Yamashita TE, Hutt E, Gottlieb SH, Dy SM, Kunther JS. Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med. 2009;24(5):592–8. doi:10.1007/s11606-009-0931-y Epub 2009 Mar 14.
Saini T, Murtagh FE, Dupont PJ, McKinnon PM, Hatfield P, Saunders Y. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliat Med. 2006;20(6):631–6.
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010;122(3):265–72. doi:10.1161/CIRCULATIONAHA.109.933275 (Epub 2010 Jul 6).
Brown MA, Collett GK, Josland EA, Foote C, Li Q, Brennan FP. CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life. CJASN. 2015;10(2):260–8. doi:10.2215/CJN.03330414.
Goebel JR, Doering LV, Shugarman LR, Asch SM, Sherbourne CD, Lanto AB, Evangelista LS, Nyamathi AM, Maliski SL, Lorenz KA. Heart failure: the hidden problem of pain. J Pain Symptom Manag. 2009;38(5):698–707. doi:10.1016/j.jpainsymman.2009.04.022 (Epub 2009 Sep 3).
Jorgenson A, Sidebottom AC, Richards H, Kirven J. A description of inpatient palliative care actions for patients with acute heart failure. Am J Hosp Palliat Care. 2016;33(9):863–70 (Epub 2015 Jun 30).
Chan KY, Cheng HW, Yap DY, Yip T, Li CS, Sham MK, Wong YC, Lau WK. Reduction of acute hospital admissions and improvement in outpatient attendance by intensified renal palliative care clinic follow-up: the Hong Kong experience. a description of inpatient palliative care actions for patients with acute heart failure. J Pain Symptom Manag. 2015;49(1):144–9. doi:10.1016/j.jpainsymman.2014.04.010 Epub 2014 May 23.
Davidson SN, Koncicki H, Brennan F. Pain in chronic kidney disease: a scoping review. Semin Dial. 2014;27(2):188–204. doi:10.1111/sdi.12196 Epub 2014 Feb 12.
Leung L. From ladder to platform: aew concept for pain management. J Prim Health Care. 2012;4(3):254–8.
Bass JB. Dyspnea. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations, 3rd edition. Boston: Butterworths; 1990. Chapter 36. http://www.ncbi.nlm.nih.gov/books/NBK357/.
Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54(5):386–96. doi:10.1016/j.jacc.2009.02.078.
Clemens KE, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support Care Cancer. 2009;17:367–77.
Cheng HWB, Sham MW, Chan KY, Li CS, Au HY, Yip T. Combination therapy with low-dose metolazone and furosemide: a “needless” approach in managing refractory fluid overload in elderly renal failure patients under palliative care. Int Urol Nephrol. 2014;46:180. doi:10.1007/s11255-014-0724-z9-1813.
Frohlich H, Katus HA, Tager T, Lossnitzer N, Leonie G, Kihm L, Zeier M, Remppis A, Frankenstein L, Schwenger V. Peritoneal ultrafiltration in end-stage chronic heart failure. Clin Kindey J. 2015;8:219–25.
Fukuta H, Goto T, Wakami K, Ohte N. Effects exercise of drug and intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2016;23(1):78–85. doi:10.1177/2047487314564729 (Epub 2014 Dec 17)
Cohen RS, Mubashir A, Wajahat R, Mani S, Hummel S, Maurer MS. The cardio-renal-anemia syndrom in elderly subjects with heart failure and a normal ejection fraction: a comparison with heart failure and low ejection fraction. Congest Heart Fail. 2006;12(4):186–91.
Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis. 2009;54(4):741–52. doi:10.1053/j.ajkd.2009.05.003.
Hedayati SS, Jiang W, O’Connor CM, et al. The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure. Am J Kidney Dis. 2004;44:207–15.
O’Connor CM, Jiang W, Kuchibhatla M, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol. 2010;56:692–9.
www.who.int/mediacenter/factsheets/fs402/en/ last updated July 2015. Accessed 12/18/15.
Temel JS, Geer JA, Muzikansky A, Gallagher ER, Admane A, Jackson VA, et al. Early palliatieve care for patients with metastatic non-small-cell lung cancer. NEJM. 2010;363(8):733–42.
Mentz R, Tulsky J, Granger B, Anstrom K, Adams P, Dodson G. The palliative care in heart failure trial: rationale and design. Am Heart J. 2014;168(5):645–51.
Baumann AJ, Wheeler DO, James MJ, Turner RN, Roberta MD, Siegel A, Navarro V. Benefit of early palliative care in end stage liver disease patients awaiting transplantation. JPSM. 2015;50(6):882–6.
Hupcey JE. The state of palliative care and heart failure. Heart Lung J Acute Crit Care. 2012;41(6):529.
Bakitas M, MacMartin M, Trzepkowski K, Robert A, Jackson L, Brown J, Dionne-Odom J, Kono A. Palliative care for heart failure patients: how many, when and why? J Cardiac Fail. 2013;19(3):193.
Greener DT, Quill T, Amir O, Szydlowski J, Gramling RE. Palliative care referal among patients hospitalized with advanced heart failure. J Palliat Med. 2014;17(10):1115–20. doi:10.1089/jpm.2013.0658.
Gallagher R, Kimel G. Letter to the editor: palliative care for heart failure: more than is written. Can J Cardiol. 2011;27:871-e7.
Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J, Dower J, Abraham J. Prognostic significance of the “surprise” question in cancer patients. J Palliat Med. 2010;13(7):837–40.
Schneider N, Oster P, Hager K, Klindtworth K. Identifying elderly heart failure patients at the end of life. Int J Cardiol. 2011;153(1):98–9. doi:10.1016/j.ijcard.2011.09.018 (Epub 2011 Oct 2)
Bernacki RE, Block SD. Communication about serious illness care goals a review and synthesis of best practices. JAMA Internal Med. 2014;174(12):1994–2003. doi:10.1001/jamainternmed.2014.5271.
Lemond L, Allen LA. Palliative care and hospice in advanced heart failure. Prog Cardiovasc Dis. 2011;54(2):168–78. doi:10.1016/j.pcad.2011.03.012.
Connors AF, Dawson NV, Desbiens NA, et al. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT principal investigators. JAMA. 1995;274(20):1591–8.
You J, Downar J, Fowler R, Lamontagne F, Ma I, Jayaraman D. Barriers to goals of care discussions with seriously ill hospitalized patients and their familiesa multicenter survey of clinicians. JAMA Internal Med. 2015;175(4):549–56. doi:10.1001/jamainternmed.2014.7732.
Cordasco KM. Obtaining informed consent from patients: brief update review. Rockville (MD): Agency for Healthcare Research and Quality (US); Making Health Care Safer II: An Updated Critical Analysis of the Evidence for Patient Safety Practices. Evidence Reports/Technology Assessments, No. 211. 2013. Chap. 39.
Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88(2):251–8.
Pollock K. Is home always the best and preferred place of death? BMJ. 2015;351:4855. doi:10.1136/bmj.h4855.
Holley JL. Advance care planning in ESRD/CKD: an evolving process. Clin J Am Soc Nephrol. 2012;7:1033–8. doi:10.2215/CJN.00580112.
Fagerlin A, Schneider CE. Enough: the failure of the living will. Hastings Cent Rep. 2004;34(2):30–42.
Wong SP, Kreuter W, O’Hare AM. Treatment intensity at the end of life in older adults receiving long-term dialysis. Arch Intern Med. 2012;172(8):661–3.
http://www.nhpco.org/hospice-statistics-research-press-room/facts-hospice-and-palliative-care. Accessed 15 Jan 2015.
Fast Fact #82 Medicare Hospice Benefit-Part I: Eligibility and Treatment Plan www.mypcnow.org.
Fast Fact and concept #87 Medicare Hospice Benefit-Part II: Places of care and Funding, www.mypcnow.org.
Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, Mor V. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291(1):88.
Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J Clin Oncol. 2010;28(29):4457.
Burton AM, Sautter JM, Tulsky JA, Lindquist JH, Hays JC, Olsen MK, Zimmerman SI, Steinhauser KE. Burden and well-being among a diverse sample of cancer, congestive heart failure, and chronic obstructive pulmonary disease caregivers. J Pain Symptom Manag. 2012;44(3):410–20. doi:10.1016/j.jpainsymman.2011.09.018 (Epub 2012 Jun 22).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Turner, R., Shaban, H. (2017). Palliation with Dual Burden of Heart and Kidney Failure: An Underutilized Strategy. In: Rangaswami, J., Lerma, E., Ronco, C. (eds) Cardio-Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-56042-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-56042-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56040-3
Online ISBN: 978-3-319-56042-7
eBook Packages: MedicineMedicine (R0)